Literature DB >> 32112159

Sarcopenia assessed by the quantity and quality of skeletal muscle is a prognostic factor for patients undergoing cardiac surgery.

Yuriko Kiriya1, Nakajima Toshiaki2, Ikuko Shibasaki3, Koji Ogata3, Hironaga Ogawa3, Yusuke Takei3, Masahiro Tezuka3, Masahiro Seki3, Takashi Kato3, Alan Kawarai Lefor4, Hirotsugu Fukuda3.   

Abstract

PURPOSE: Sarcopenia was assessed as a prognostic factor for patients undergoing cardiac surgery by evaluating the quantity and quality of skeletal muscle.
METHODS: Sarcopenia was assessed by perioperative abdominal computed tomography using the total psoas muscle index (TPI) and intra-muscular adipose tissue content (IMAC). Patients were classified into high- (HT, n = 143) and low- (LT, n = 63) TPI groups and low- (LI, n = 122) and high- (HI, n = 84) IMAC groups.
RESULTS: There were significantly more complications in the LT and HI groups than in the HT and LI groups. (HT 15.4% vs. LT 30.2%, P = 0.014) (LI 11.5% vs. HI 31.1%, P < 0.001). There were more respiratory complications in the LT group (HT 0% vs. LT 6.3%, P = 0.002) and more surgical site infections in the HI group than in the LI group (LI 0.8% vs. HI 7.1%, P = 0.014). A multivariable analysis showed that low TPI and high IMAC significantly predicted more major complications than other combinations (odds ratio [OR] 2.375; 95% confidence interval [CI] 1.152-5.783; P = 0.036, OR 3.973; 95% CI 1.737-9.088; P = 0.001).
CONCLUSIONS: Sarcopenia is a risk factor for complications. The quantity and quality of muscle must be assessed to predict operative outcomes. CLINICAL TRIAL REGISTRATION NUMBER: UMIN000027077.

Entities:  

Keywords:  Cardiac surgery; Frailty; Preoperative risk assessment; Sarcopenia

Year:  2020        PMID: 32112159     DOI: 10.1007/s00595-020-01977-w

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  5 in total

1.  Sarcopenia is poor risk for unfavorable short- and long-term outcomes in stage I non-small cell lung cancer.

Authors:  Yusuke Takahashi; Shigeki Suzuki; Kenichi Hamada; Takeo Nakada; Yuko Oya; Noriaki Sakakura; Hirokazu Matsushita; Hiroaki Kuroda
Journal:  Ann Transl Med       Date:  2021-02

2.  The Psoas Muscle Index Is Associated with Prognosis in Elderly Patients Undergoing Cardiovascular Surgery.

Authors:  Yudai Iwasaki; Junji Shiotsuka; Alan Kawarai Lefor; Masamitsu Sanui
Journal:  Anesth Pain Med       Date:  2021-10-12

3.  Muscle Quality Predicts Outcomes after Surgery for Early-Stage Non-Small-Cell Lung Cancer.

Authors:  Atsushi Kamigaichi; Hiroaki Harada; Satoshi Shibata
Journal:  Ann Thorac Cardiovasc Surg       Date:  2022-03-16       Impact factor: 1.889

4.  Preoperative Serum GDF-15, Endothelin-1 Levels, and Intraoperative Factors as Short-Term Operative Risks for Patients Undergoing Cardiovascular Surgery.

Authors:  Takashi Kato; Toshiaki Nakajima; Taira Fukuda; Ikuko Shibasaki; Takaaki Hasegawa; Koji Ogata; Hironaga Ogawa; Shotaro Hirota; Hirotaka Ohashi; Shunsuke Saito; Yusuke Takei; Masahiro Tezuka; Masahiro Seki; Toshiyuki Kuwata; Masashi Sakuma; Shichiro Abe; Shigeru Toyoda; Teruo Inoue; Hirotsugu Fukuda
Journal:  J Clin Med       Date:  2021-05-02       Impact factor: 4.241

5.  Reversal of deficits in aged skeletal muscle during disuse and recovery in response to treatment with a secrotome product derived from partially differentiated human pluripotent stem cells.

Authors:  Dennis K Fix; Ziad S Mahmassani; Jonathan J Petrocelli; Naomi M M P de Hart; Patrick J Ferrara; Jessie S Painter; Gabriel Nistor; Thomas E Lane; Hans S Keirstead; Micah J Drummond
Journal:  Geroscience       Date:  2021-08-24       Impact factor: 7.713

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.